These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 1903847

  • 1. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer.
    Nemunaitis J, Rabinowe SN, Singer JW, Bierman PJ, Vose JM, Freedman AS, Onetto N, Gillis S, Oette D, Gold M.
    N Engl J Med; 1991 Jun 20; 324(25):1773-8. PubMed ID: 1903847
    [Abstract] [Full Text] [Related]

  • 2. Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trial.
    Luce BR, Singer JW, Weschler JM, Buckner CD, Sheingold SH, Shannon-Dorcy K, Appelbaum FR, Nemunaitis J.
    Pharmacoeconomics; 1994 Jul 20; 6(1):42-8. PubMed ID: 10172083
    [Abstract] [Full Text] [Related]

  • 3. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation.
    Nemunaitis J, Rosenfeld CS, Ash R, Freedman MH, Deeg HJ, Appelbaum F, Singer JW, Flomenberg N, Dalton W, Elfenbein GJ.
    Bone Marrow Transplant; 1995 Jun 20; 15(6):949-54. PubMed ID: 7581096
    [Abstract] [Full Text] [Related]

  • 4. Retrospective analysis of infectious disease in patients who received recombinant human granulocyte-macrophage colony-stimulating factor versus patients not receiving a cytokine who underwent autologous bone marrow transplantation for treatment of lymphoid cancer.
    Nemunaitis J, Buckner CD, Dorsey KS, Willis D, Meyer W, Appelbaum F.
    Am J Clin Oncol; 1998 Aug 20; 21(4):341-6. PubMed ID: 9708630
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) following autologous marrow transplantation in man.
    Appelbaum FR, Nemunaitis J.
    Behring Inst Mitt; 1988 Aug 20; (83):145-8. PubMed ID: 3071330
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies.
    Rabinowe SN, Neuberg D, Bierman PJ, Vose JM, Nemunaitis J, Singer JW, Freedman AS, Mauch P, Demetri G, Onetto N.
    Blood; 1993 Apr 01; 81(7):1903-8. PubMed ID: 8461475
    [Abstract] [Full Text] [Related]

  • 7. Use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with lymphoid malignancies transplanted with unpurged or adjusted-dose mafosfamide-purged autologous marrow.
    Carlo-Stella C, Mangoni L, Almici C, Cottafavi L, Meloni G, Mandelli F, Rizzoli V.
    Blood; 1992 Nov 01; 80(9):2412-8. PubMed ID: 1421413
    [Abstract] [Full Text] [Related]

  • 8. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J, Terol MJ, Urbano-Ispizua A, Rovira M, Marin P, Carreras E, Batlle M, Rozman C.
    Exp Hematol; 1994 Jul 01; 22(7):566-72. PubMed ID: 8013572
    [Abstract] [Full Text] [Related]

  • 9. The use of recombinant human granulocyte-macrophage colony stimulating factor in autologous bone marrow transplantation.
    Nemunaitis J, Singer JW.
    Am J Clin Oncol; 1991 Jul 01; 14 Suppl 1():S15-8. PubMed ID: 2048559
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation.
    Nemunaitis J, Buckner CD, Appelbaum FR, Higano CS, Mori M, Bianco J, Epstein C, Lipani J, Hansen J, Storb R.
    Blood; 1991 May 01; 77(9):2065-71. PubMed ID: 1902125
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma.
    Link H, Boogaerts MA, Carella AM, Ferrant A, Gadner H, Gorin NC, Harabacz I, Harousseau JL, Hervé P, Holldack J.
    Blood; 1992 Nov 01; 80(9):2188-95. PubMed ID: 1421390
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors.
    Nemunaitis J, Anasetti C, Storb R, Bianco JA, Buckner CD, Onetto N, Martin P, Sanders J, Sullivan K, Mori M.
    Blood; 1992 May 15; 79(10):2572-7. PubMed ID: 1586709
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy.
    Nemunaitis J, Singer JW, Buckner CD, Mori T, Laponi J, Hill R, Storb R, Sullivan KM, Hansen JA, Appelbaum FR.
    Bone Marrow Transplant; 1991 Jan 15; 7(1):49-52. PubMed ID: 2043878
    [Abstract] [Full Text] [Related]

  • 20. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
    Sallerfors B, Olofsson T, Lenhoff S.
    Bone Marrow Transplant; 1991 Sep 15; 8(3):191-5. PubMed ID: 1720339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.